Shanghai Public Health Clinical Center;
Fudan University;
Shanghai 201508;
China;
Institute of Infection;
Immunology and Tumor Microenvironment;
Hubei Province Key Laboratory of Occupational Hazard Identification and Control;
Medical College;
Wuhan University of Science and Technology;
Wuhan 430065;
China;
Joint Laboratory of Infectious Diseases and Health;
Wuhan Institute of Virology&Wuhan Jinyintan Hospital;
Wuhan Institute of Virology;
Center for Biosafety Mega-Science;
Chinese Academy of Sciences;
Wuhan 430023;
China;
State Key Laboratory of Virology;
Wuhan Institute of Virology;
Center for Biosafety Mega-Science;
Chinese Academy of Sciences;
Wuhan 430071;
China;
Center for Translational Medicine;
Jinyintan Hospital;
Wuhan 430023;
China;
Joint Laboratory of Infectious Diseases and Health;
Wuhan Institute of Virology&Wuhan Jinyintan Hospital;
Wuhan Jinyintan Hospital;
Wuhan 430023;
China;
Department of Laboratory Medicine;
Maternal and Child Health Hospital of Hubei Province;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430070;
China;
School of Public Health(Shenzhen);
Sun Yat-sen University;
Shenzhen 518107;
China;
Institute of Medical Biology;
Chinese Academy of Medical Sciences&Peking Union Medical College;
Kunming 650018;
China;
University of Chinese Academy of Sciences;
Beijing 100049;
China;
The Office of Drug Clinical Trial Institution;
Jinyintan Hospital;
Wuhan 430023;
China;
Department of Critical Care Medicine;
Union Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
COVID-19; recovered individuals; lymphocyte subsets; phenotypic alteration; potential dysfunction;